Cowgill et al. report apo, inhibited, and desensitized structures of the human ρ1 GABAA receptor. These structures, combined with supporting simulations and electrophysiology experiments, reveal a more compact neurotransmitter-binding site that defines the unique function and pharmacology of ρ-type GABAA receptors relative to canonical synaptic GABAA receptors.